APA aipamena

Rangachari, D., VanderLaan, P. A., Shea, M., Le, X., Huberman, M. S., Kobayashi, S. S., & Costa, D. B. (2017). Correlation between classic driver oncogene mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% expression in lung adenocarcinoma. J Thorac Oncol.

Chicago Style aipamena

Rangachari, Deepa, Paul A. VanderLaan, Meghan Shea, Xiuning Le, Mark S. Huberman, Susumu S. Kobayashi, and Daniel B. Costa. "Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% Expression in Lung Adenocarcinoma." J Thorac Oncol 2017.

MLA aipamena

Rangachari, Deepa, et al. "Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% Expression in Lung Adenocarcinoma." J Thorac Oncol 2017.